You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Drug Price Trends for DICLOFENAC SOD DR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DICLOFENAC SOD DR

Average Pharmacy Cost for DICLOFENAC SOD DR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DICLOFENAC SOD DR 50 MG TAB 61442-0102-01 0.08554 EACH 2025-02-19
DICLOFENAC SOD DR 25 MG TAB 72888-0109-01 0.73728 EACH 2025-02-19
DICLOFENAC SOD DR 75 MG TAB 72888-0111-60 0.08864 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Diclofenac Sodium Market Analysis and Price Projections

Market Overview

Diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID), is widely used to treat various inflammatory and pain-related conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and sports injuries. Here’s a comprehensive analysis of the diclofenac sodium market, including its size, growth projections, segmentation, and pricing.

Market Size and Growth Projections

The global diclofenac sodium market is experiencing significant growth driven by increasing demand for anti-inflammatory medications. As of 2024, the market size was valued at USD 2.5 billion and is projected to reach USD 3.7 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.5% from 2024 to 2031[1].

Market Segmentation

By Type

The diclofenac sodium market is segmented into tablets and injections. Tablets hold the major share in the market due to their widespread use and the availability of various formulations and combinations. This segment is expected to continue dominating the market due to its ease of administration and patient preference[1].

By Application

The market is segmented into elderly and adult applications. The elderly segment holds a significant share due to the higher incidence of inflammatory diseases such as osteoarthritis and rheumatoid arthritis in this age group. The elderly population's low immune system and increased rate of illnesses further drive the demand for diclofenac sodium[1].

By Geography

Geographically, the market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the market due to factors such as an expanding senior population, rising prevalence of cardiovascular illnesses, chronic pain management, higher healthcare expenditure, and a strong medical infrastructure in the U.S. and Canada. Asia-Pacific is also expected to offer lucrative growth opportunities due to robust medical advertisements and government support for medical development through Foreign Direct Investment (FDI)[1][4].

Drivers and Restraints

Drivers

  • Increasing Geriatric Population: The growing number of geriatric individuals globally is a significant driver for the market. This population is highly susceptible to inflammatory and pain-related conditions, fueling the demand for diclofenac sodium[4].
  • Sports Injuries: The use of diclofenac topical treatments for sports-related injuries and conditions such as knee osteoarthritis is another key driver[1][4].
  • Robust Medical Infrastructure: Regions with strong medical infrastructure, such as North America, contribute to the market's growth by ensuring widespread availability and awareness of diclofenac sodium[1][4].

Restraints

  • Side Effects: Cases of unwanted side effects, including thrombotic cardiovascular events, gastrointestinal effects, and potential bleeding or ulceration, can hamper market growth. These side effects are particularly concerning for the geriatric population, which is a major consumer segment[4].
  • Drug Patent Expiration: The expiration of drug patents can lead to increased competition from generic versions, potentially affecting the market growth of branded diclofenac sodium products[1].

Pricing and Cost Analysis

The cost of diclofenac sodium varies based on the formulation, dosage, and region.

  • Oral Delayed Release Tablets: For example, the cost for diclofenac sodium 75 mg oral delayed release tablets can range from $14 to $15 for a supply of 10 tablets, depending on the pharmacy and any applicable discounts or coupons[2][3].
  • Topical Solutions: Pennsaid, a brand-name topical solution for osteoarthritis of the knee, can cost around $55 per fill, with savings programs available that can reduce the cost by up to $46[5].

Price Projections

Given the projected market growth, the prices of diclofenac sodium are likely to remain competitive. However, the introduction of new formulations and the increasing demand for anti-inflammatory treatments with fewer side effects could influence pricing. Here are some key points to consider:

  • Generic Competition: As patents expire, generic versions of diclofenac sodium may enter the market, potentially reducing prices and increasing competition[1].
  • Innovative Formulations: The development of new and improved formulations, such as topical sprays and extended-release tablets, could maintain or slightly increase prices due to their enhanced efficacy and convenience[4].
  • Geographical Variations: Prices can vary significantly across different regions due to factors such as healthcare expenditure, insurance coverage, and local regulations[1][4].

Competitive Landscape

The global diclofenac sodium market is highly competitive, with several major players including:

  • Auro Laboratories Limited
  • Henan Dongtai Pharmaceutical Co.
  • Bayer AG
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Istituto Biochimico Italiano G. Lorenzini S.p.A.
  • Dezhou Deyao Pharmaceutical Co., Ltd.[1]

These companies are focusing on key development strategies such as product innovation, market expansion, and strategic partnerships to maintain their market share.

Key Takeaways

  • The global diclofenac sodium market is projected to grow from USD 2.5 billion in 2024 to USD 3.7 billion by 2031.
  • The market is driven by the increasing geriatric population and the need for effective anti-inflammatory treatments.
  • North America and Asia-Pacific are expected to be key regions for market growth.
  • Side effects and drug patent expirations are significant restraints.
  • Prices vary based on formulation and region, with potential for generic competition to influence pricing.

FAQs

What is the projected market size of diclofenac sodium by 2031?

The global diclofenac sodium market is projected to reach USD 3.7 billion by 2031[1].

Which region is expected to dominate the diclofenac sodium market?

North America is expected to dominate the market due to its robust medical infrastructure and high healthcare expenditure[1][4].

What are the main drivers of the diclofenac sodium market?

The main drivers include the increasing geriatric population, sports injuries, and robust medical infrastructure in key regions[1][4].

What are the potential restraints for the diclofenac sodium market?

Significant restraints include unwanted side effects and the expiration of drug patents[1][4].

How does the cost of diclofenac sodium vary?

The cost varies based on the formulation, dosage, and region, with prices ranging from a few dollars for oral tablets to higher costs for topical solutions and extended-release formulations[2][3][5].

Sources

  1. Verified Market Research: Diclofenac Sodium Market Size, Share, Trends & Forecast.
  2. Drugs.com: Diclofenac Prices, Coupons, Copay Cards & Patient Assistance.
  3. SingleCare: Diclofenac Sodium Coupons & Prices.
  4. IndustryARC: Diclofenac Market Size Report, 2022-2027.
  5. MedicalNewsToday: Pennsaid cost 2024: Coupons and more.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.